These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25546431)

  • 21. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
    Takei H; Kurosumi M; Yoshida T; Ishikawa Y; Hayashi Y; Ninomiya J; Tozuka K; Oba H; Inoue K; Nagai S; Saito Y; Kazumoto T; Saitoh J; Tabei T
    Breast Cancer; 2010; 17(1):9-16. PubMed ID: 19701679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
    Saidi RF; Dudrick PS; Remine SG; Mittal VK
    Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].
    Cusumano P; Bleret V; Nos C; Hustinx R; Lilet H; Gomez P; Lifrange E
    Rev Med Liege; 2011; 66(5-6):336-40. PubMed ID: 21826973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up.
    Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH
    Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sentinel lymph node biopsy in breast cancer].
    Shen K; Nirmal L; Han Q; Wu J; Lu J; Zhang J; Liu G; Shao Z; Shen Z
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):347-50. PubMed ID: 12133338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy.
    Imoto S; Isaka H; Sakemura N; Ito H; Imi K; Miyamoto K
    Breast Cancer; 2012 Apr; 19(2):104-9. PubMed ID: 22038672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sentinel lymph node biopsy and low axillary node sampling for breast cancer].
    Sawai K; Nakajima H; Ohe S; Mizuta N; Sakaguchi K; Hachimine Y
    Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):825-30. PubMed ID: 12478860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: a decision analysis.
    Wong SL; Abell TD; Chao C; Edwards MJ; McMasters KM
    Cancer; 2002 Aug; 95(3):478-87. PubMed ID: 12209739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations.
    D'Angelo-Donovan DD; Dickson-Witmer D; Petrelli NJ
    Surg Oncol; 2012 Sep; 21(3):196-200. PubMed ID: 22237143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of sentinel lymph node biopsy in breast cancer, in and out of vogue?
    Jaffer S; Bleiweiss IJ
    Adv Anat Pathol; 2014 Nov; 21(6):433-42. PubMed ID: 25299312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
    Port ER; Patil S; Stempel M; Morrow M; Cody HS
    Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
    Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
    Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.